Robert J. Riley - Concepedia

Author

Robert J. Riley

Loughborough University

Also Known As

R J Riley, R. J. Riley, R.J. Riley, Robert J Riley, Robert J. Riley, Robert Riley

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

Loughborough University AstraZeneca (United Kingdom)Evotec (United Kingdom)AstraZeneca (Singapore)Ninewells Hospital

About

Robert J. Riley is an author at Loughborough University specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	22	1.1K
2	Natural Sciences	5	5	222
3	Health Sciences	2	2	145
4	Engineering	1	1	48
5	Allergy	1	1	44

Robert J. Riley

Publications

Citations

H-Index

Page 1

	Year	Citations
The Influence of Nonspecific Microsomal Binding on Apparent Intrinsic Clearance, and Its Prediction from Physicochemical Properties Rupert P. Austin, Patrick Barton, Scott L. Cockroft, Drug Metabolism and Disposition	2002	399
A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES Robert J. Riley, Dermot F. McGinnity, Rupert P. Austin Drug Metabolism and Disposition	2005	364
EVALUATION OF FRESH AND CRYOPRESERVED HEPATOCYTES AS IN VITRO DRUG METABOLISM TOOLS FOR THE PREDICTION OF METABOLIC CLEARANCE Dermot F. McGinnity, Matthew G. Soars, Richard A. Urbanowicz, Drug Metabolism and Disposition	2004	268
From ATP to AZD6140: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis Brian Springthorpe, A. S. Bailey, Patrick Barton, Bioorganic & Medicinal Chemistry Letters ThrombosisPlatelet Aggregation InhibitorsBiochemistryBlood PlateletMedicine	2007	233
In Vitro Analysis of Human Drug Glucuronidation and Prediction of in Vivo Metabolic Clearance Matthew G. Soars, Brian Burchell, Robert J. Riley Journal of Pharmacology and Experimental Therapeutics	2002	226
THE BINDING OF DRUGS TO HEPATOCYTES AND ITS RELATIONSHIP TO PHYSICOCHEMICAL PROPERTIES Rupert P. Austin, Patrick Barton, Sarfraz Mohmed, Drug Metabolism and Disposition	2004	170
Use of Hepatocytes to Assess the Contribution of Hepatic Uptake to Clearance in Vivo Matthew G. Soars, Ken Grime, Joanne L. Sproston, Drug Metabolism and Disposition	2007	142
Automated Definition of the Enzymology of Drug Oxidation by the Major Human Drug Metabolizing Cytochrome P450s Dermot F. McGinnity, Alison J. Parker, Matthew G. Soars, Drug Metabolism and Disposition	2000	122
Evaluation of Human Pharmacokinetics, Therapeutic Dose and Exposure Predictions Using Marketed Oral Drugs Dermot F. McGinnity, John Collington, Rupert P. Austin, Current Drug Metabolism Marketed Oral DrugsPharmacodynamic ModelingTranslational MedicinePharmacological StudyBioanalysis	2007	122
Development of a Generalized, Quantitative Physicochemical Model of CYP3A4 Inhibition for Use in Early Drug Discovery Robert J. Riley, Alexandra J. Parker, Steve Trigg, Pharmaceutical Research	2001	109

Page 1